QIC was founded in 2020 to fast and accurately develop cures for various diseases that people suffer from.

Leadership

  • Hwanho Choi, PhD, MD

    Chief Executive Officer, Founder

    PhD in Chemistry, University of Oxford, UK
    MD, Kyunghee University, Korea
    BS in Physics, Seoul National University

    Researcher, University of Oxford, UK
    Senior Researcher, KRIBB, Korea
    Visiting Researcher, KAIST, Korea

  • Hongsuk Kang, PhD

    Chief Technology Officer, Co-Founder

    PhD in Chemical Physics, University of Maryland
    BS in Physics, Seoul National University

    Researcher, IBM Thomas J. Watson center, USA
    Researcher, KRIBB, Korea
    Progammer, IUTECH Inc., Korea

  • Hojeong Pak, MD

    Chief Research Officer, Co-Founder

    MD, Chonbuk National University, Korea
    MS, Seoul St. Mary’s Hospital


    Director, Say Medical Clinic, Korea
    Assistant Professor, Seoul St. Mary’s Hospital
    Clinical Instructor, Seoul St. Mary’s Hospital

What we focus on

  • Quantum mechanics is a branch of physics that deals with the behavior of particles on a very small scale, such as atoms and subatomic particles. It is a fundamental theory that has been successful in explaining a wide range of phenomena in the physical world. For a decade, we have begun to explore the potential applications of quantum mechanics in the field of drug development. Quantum mechanics can be used to study the structure and behavior of molecules, which can help researchers design and develop new drugs that are more effective and have fewer side effects. Additionally, quantum mechanics can be used to simulate chemical reactions, which can help researchers understand how drugs interact with biological systems and predict their effects on the body. Overall, the role of quantum mechanics in drug development is to provide a deeper understanding of the fundamental principles governing the behavior of molecules, which can aid in the design and development of new and improved drugs.

  • QSAR, or quantitative structure-activity relationship, is a computational method that uses mathematical and statistical models to predict the biological activity of a chemical compound based on its molecular structure. In drug development, QSAR can be used to identify potential drug candidates, assess their potential efficacy and toxicity, and guide the optimization of their molecular structure for improved activity and safety. This allows for more efficient and targeted drug discovery and development, reducing the time and resources needed to bring new drugs to market.

  • AI algorithms can quickly and accurately analyze large amounts of data to identify patterns and relationships that may be missed by human analysts. This can help identify potential drug targets and optimize drug design. AI can automate the process of drug discovery and development, reducing the need for labor-intensive manual processes and enabling faster progress. AI can help identify potential side effects and adverse reactions of new drugs, allowing for more efficient and safe drug development. AI can help reduce the costs and time associated with drug development by streamlining processes and enabling more efficient decision-making. AI can help identify new potential uses for existing drugs, expanding their potential market and improving patient outcomes.